Clinical highlights from the National Cancer Data Base, 2000

Authors

  • Mr. Andrew K. Stewart MA,

    1. Commission on Cancer of the American College of Surgeons, Chicago, IL, and the American Cancer Society, Atlanta, GA
    2. Stewart is Acting Manager of Clinical Information, Commission on Cancer, American College of Surgeons, Chicago, IL
    Search for more papers by this author
  • Dr. Kirby I. Bland MD,

    1. Commission on Cancer of the American College of Surgeons, Chicago, IL, and the American Cancer Society, Atlanta, GA
    2. Bland is Professor and Chair of the Department of Surgery, University of Alabama at Birmingham, Birmingham, AL
    Search for more papers by this author
  • Dr. Lamar S. Mcginnis Jr MD,

    1. Commission on Cancer of the American College of Surgeons, Chicago, IL, and the American Cancer Society, Atlanta, GA
    2. McGinnis is a Medical Consultant for the American Cancer Society, Atlanta, GA
    Search for more papers by this author
  • Dr. Monica Morrow MD,

    1. Commission on Cancer of the American College of Surgeons, Chicago, IL, and the American Cancer Society, Atlanta, GA
    2. Morrow is Director of the Commission on Cancer, American College of Surgeons, and Professor of Surgery and Director of the Lynn Sage Breast Cancer Center at Northwestern University Medical School, Chicago, IL
    Search for more papers by this author
  • Dr. Harmon J. Eyre MD

    1. Commission on Cancer of the American College of Surgeons, Chicago, IL, and the American Cancer Society, Atlanta, GA
    2. Eyre is Executive Vice President for Research and Medical Affairs, American Cancer Society, Atlanta, GA., and the newly named Editor-in-Chief of CA
    Search for more papers by this author

Abstract

The National Cancer Data Base (NCDB) is the empirical data collection and analysis arm of the American College of Surgeons Commission on Cancer, and is supported in part by the American Cancer Society. The NCDB collects oncology patient demographic information, diagnostic and treatment information, and outcomes data from a broad spectrum of hospital-based cancer registries throughout the US, ranging from large research and teaching facilities to small community hospitals. Through this unique network, data are aggregated and reported back to participating hospitals to allow individual facilities to evaluate local patient care practices and outcomes.

This article highlights the principal findings of articles published in 1999 and early 2000 that used NCDB data as the empirical basis of their analyses. Included among these are articles on breast cancer, gastric carcinoma, head and neck cancers, leukemia, liver carcinoma, lung cancer, parathyroid tumors, prostate carcinoma, small bowel adenocarcinoma, testicular malignancies, and vulvar melanoma. These articles are based on cases diagnosed between 1985 and 1996. The NCDB has accrued more than 6.4 million cancer cases for this time period. Sufficient numbers of rare cancers are reported to the NCDB to permit some types of clinical evaluation not possible using other data sources.

Ancillary